Nscale’s updated IPO prospectus
Q3 revenue $307.5M (+1,344%), net loss $1.69B, and more funding needed for 2027 commitments tied to its Anthropic deal
Confirmed
The takeaway
Nscale’s IPO prospectus, updated on Nov 12, 2026, shows Q3 revenue of $307.5M, up 1,344% year on year, and a net loss of $1.69B (Q2: $1.02B).
Status
- Claim
Confirmed
- Our reporting
- High confidence
- Importance
- 2 of 5
- Last verified
- 13 November 2026
Your AI and this story
- GPT-6.2 Astra165 days after its cutoff
- Claude Opus 5.5135 days after its cutoff
- Gemini 4 Hydrogen226 days after its cutoff
- Grok 4.7165 days after its cutoff
None of these four assistants can know about it. The closest, Claude Opus 5.5, stops 135 days before it.
Key facts
- Q3 2026 revenue $307.5M (+1,344% YoY); Q2 $140.6M (+1,252%); Q3 net loss $1.69B vs $1.02B in Q2 (CNBC)
- FT (headline): filing says Nscale needs more funding for 2027 commitments after ordering Nvidia chips for a $45B Anthropic deal; IPO plan valued around $35B
- Anthropic exercised a right in late September to contract more capacity at Nscale’s West Virginia site; Microsoft walked away from a planned England site and reportedly did not renew a Texas contract, though the filing still expects Microsoft to be a ‘significant customer in future periods’
- NYSE listing; offering size not disclosed
What happened
Nscale is one of the neoclouds financing GPU capacity for frontier labs. Its prospectus update came the day Nvidia’s CEO resigned and a week before Anthropic’s own IPO.
Why it matters
It shows the financing strain behind lab compute deals: revenue grows fast while losses and capital needs grow faster, and a single lab contract can drive a supplier’s funding needs.
Sources
2 sources from 2 sites. Numbers match the chips in the text.
2 sources: 2 press
Press
Changes
- Filed (news agent)